The Latest Competitor Analysis Report on Emerging Diabetes Drugs...

Sep 3, 2008 - Research and Markets has announced the addition of the "Competitor Analysis: Emerging Diabetes Drugs" report to their offering.

Lieutenant governor's cancer is slow to grow

Lt. Gov. Catherine Baker Knoll suffers from a rare cancer that usually is slow-growing, according to medical experts.

Experiments Could Lead To New Treatments For Neuroblastoma

The cancer's victims average 2 years old when the disease is detected, most often by a parent feeling a lump in a child's abdomen.

Potential New Treatments For Deadly Cancer Which Primarily Strikes Infants

Main Category: Cancer / Oncology Also Included In: Pediatrics / Children's Health Article Date: 18 Aug 2008 Neuroblastoma is one of the most devastating diagnoses a child can receive.

Experiments could lead to new treatments for neuroblastoma

Neuroblastoma is one of the most devastating diagnoses a child can receive. The cancer's victims average 2 years old when the disease is detected, most often by a parent feeling a lump in a child's abdomen.

Do not be concerned [Pharyngula]

Category: Weirdness Posted on: June 5, 2008 4:27 PM, by PZ Myers Several people have written to me expressing their concern over the recent publication of this paper: Evidence for Intelligent Design in ...

Treatment for GERD- 8 Free Tips to Naturally Treat Acid Reflux and Heartburn

Is there an effective natural treatment for GERD? Yes and here are 8 free tips to naturally treat acid reflux and never have heartbun again! You are not alone and you are not the only one searching for a ...

Lilly and Transition Therapeutics announce licensing and collaboration agreement

Eli Lilly and Company and Transition Therapeutics Inc. has announced that the two companies have entered into a licensing and collaboration agreement granting Lilly exclusive worldwide rights to develop and ...

Lilly, Transition Enter Diabetes Pact

Eli Lilly and Co. and Transition Therapeutics, Inc. have entered into a licensing and collaboration agreement granting Lilly exclusive worldwide rights to develop and commercialize Transition's gastrin-based ...

More...

Eli Lilly and Company and Transition Therapeutics Inc. today announced that the two companies have entered into a licensing and collaboration agreement granting Lilly exclusive worldwide rights to develop and ...